Late-onset and long-lasting autoimmune neutropenia: an analysis from the Italian Neutropenia Registry
Open Access
- 18 November 2020
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (22) , 5644-5649
Abstract
Primary autoimmune neutropenia (pAN) is typified by onset in early infancy and a mild/moderate phenotype that resolves within 3 years of diagnosis. In contrast, secondary AN is classically an adult disease associated with malignancy, autoimmunity, immunodeficiency, viral infection, or drugs. This study describes a cohort of 79 children from the Italian Registry who, although resembling pAN, did not fully match the criteria for pAN because neutropenia either appeared after age 5 years (LO-Np) or lasted longer than 3 years (LL-Np). These 2 categories compared with classical pAN showed a far inferior rate of resolution (P < .001), lower severity of neutropenia (P = .03), leukopenia (P < .001), lymphopenia (P < .001) with low B+ (P = .001), increased need of granulocyte colony-stimulating factor (P = .04), and increased frequency of autoimmunity over the disease course (P < .001). A paired comparison between LO-Np and LL-Np suggested that LO-Np had a lower rate of resolution (P < .001) and lower white blood cell (P < .001) and lymphocyte (P < .001) values, higher occurrence of apthae (P = .008), and a stronger association with autoimmune diseases/markers (P = .001) than LL-Np, thus suggesting a more pronounced autoimmune signature for LO-Np. A next-generation sequencing panel applied in a small subgroup of LO-Np and LL-Np patients identified variants related to immune dysregulations. Overall, these findings indicate that there are important differences among pAN LL-Np and LO-Np. Forms rising after 3 years of age, with low tendency to resolution, require tight monitoring and extensive immune investigations aimed to early identify underlying immunologic disease.Keywords
This publication has 18 references indexed in Scilit:
- The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiencyJournal of Allergy and Clinical Immunology, 2016
- Autoimmune neutropenia of infancy: Data from the Italian neutropenia registryAmerican Journal of Hematology, 2015
- External quality assessment of human neutrophil antigen (HNA)‐specific antibody detection and HNA genotyping from 2000 to 2012Vox Sanguinis, 2013
- Congenital and acquired neutropenias consensus guidelines on therapy and follow‐up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato‐Oncologia Pediatrica)American Journal of Hematology, 2011
- How I treat common variable immune deficiencyBlood, 2010
- The ITP syndrome: pathogenic and clinical diversityBlood, 2009
- TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromesBlood, 2008
- Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: Clinical and immunologic outcomes in heterozygotesJournal of Allergy and Clinical Immunology, 2007
- Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humansNature Genetics, 2005
- Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical courseVox Sanguinis, 2005